Hill's Pet Nutrition, Inc.

Described herein are pet food compositions for reducing circulating pro-inflammatory cytokines in companion animals. Methods of making and using the same are also described.

Described herein are pet food compositions comprising propolis, along with methods of making and using same. According to an aspect of the disclosure, provided is a pet food composition comprising propolis in an amount greater than about 0.1 wt. %; about 10 to about 40 wt. % of protein; about 9 to about 25 wt. % of a fat; about 10 to about 90 wt. % of a carbohydrate, wherein all weight percentages are based on the total weight of the food composition.

Described herein are pet food compositions comprising—in relevant part—neutral detergent fiber and crude fiber in amounts, which are effective in inducing satiety and supporting healthy weight management. Methods of making and using these pet food compositions are also described.

Described herein are systems and methods for tracking an animal comprising—for example: an electronic device configured to be coupled to an animal, the electronic device comprising: one or more sensors comprising at least one of an accelerometer, a gyroscope, or a magnetometer, the one or more sensors configured to determine location or movement information relating to the animal; a memory device configured to store the location or movement information relating to the animal; a communication interface configured to wirelessly communicate the location or movement information to an external device; and a battery device for providing power the at least one of the one or more sensors or the communication interface; and a charging device configured to wirelessly provide power to the battery device.

Methods and kits for assessing the propensity of developing urolithiasis, kidney disease, or bladder disease in pets; and compositions to treat such conditions are described herein.

Disclosed herein are pet food compositions for treating or preventing-inter alia-struvite urolithiasis comprising at least one of caprylic acid and capric acid; and at least one of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

Described herein are pet food compositions comprising greater than 35 wt. % fat, greater than 10 wt. % fiber, protein, low levels of carbohydrates, and a ketogenic ratio greater than or equal to 1.5. Methods of making and using these pet food compositions are also described herein.

Disclosed herein are pet food compositions for treating or preventing—inter alia—struvite urolithiasis comprising at N least one of caprylic acid and capric acid; and at least one of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

Described herein are methods and kits for—inter alia—identifying a companion animal having an increased risk of developing interstitial cystitis; along with compositions for treating same.

Described herein are pet food compositions for enhancing nicotinamide adenine dinucleotide metabolism and increasing levels of nicotinamide adenine dinucleotide oxidized form, the food composition including a protein, a carbohydrate, and a dietary fiber that includes insoluble fiber and soluble fiber in a weight ratio ranging from about 8:1 to about 14:1, whereby the dietary fiber is present in an amount ranging from about 2 wt. % to about 10 wt. % based on the total weight of the food composition.